Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pol J Vet Sci ; 16(1): 193-7, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23691596

RESUMO

The literature analysed by REQUEST (REassesing QUinolone European STandard) using inclusion and exclusion criteria allows to make the conclusion that the proper use of fluoroquinolones (FQ) in canine colitis requires rigorously performed qualification to specific antimicrobial treatment. An infectious agent responsive to FQ therapy plays an integral role in the clinical manifestation of canine colitis, especially histiocytic ulcerative colitis (HUC) in young Boxer dogs. This supports the use of FQ in these cases. The Request guidelines for proper use of FQ in canine colitis is established, according to the available literature data.


Assuntos
Antibacterianos/uso terapêutico , Colite/veterinária , Doenças do Cão/tratamento farmacológico , Quinolonas/uso terapêutico , Animais , Colite/tratamento farmacológico , Cães
2.
Schweiz Arch Tierheilkd ; 151(2): 69-74, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19189251

RESUMO

Multiple organ dysfunction syndrome is defined as the presence of altered organ function in an acutely ill patient such that homeostasis could not be mantained without intervention. It is reported that mortality rate in humans with 4 organ systems failing reaches nearly 100%, while there are few publications documenting this syndrome in dogs. To the author's knowledge, this is the first report that describes the clinical manifestations and the favourable outcome to intensive medical care in a dog with Klebsiella pneumoniae septicemia and multiple organ dysfunction with 6 organ systems failing. Derangement of cardiovascular, respiratory, gastrointestinal, pancreatic, renal and coagulation system developed. This dog manifested reversible myocardial depression that is a common complication of sepsis in people but it is rarely reported in dogs.


Assuntos
Doenças do Cão/diagnóstico , Infecções por Klebsiella/veterinária , Klebsiella pneumoniae , Insuficiência de Múltiplos Órgãos/veterinária , Animais , Doenças do Cão/terapia , Cães , Infecções por Klebsiella/complicações , Infecções por Klebsiella/diagnóstico , Infecções por Klebsiella/terapia , Masculino , Insuficiência de Múltiplos Órgãos/diagnóstico , Insuficiência de Múltiplos Órgãos/etiologia , Insuficiência de Múltiplos Órgãos/terapia , Prognóstico , Índice de Gravidade de Doença , Resultado do Tratamento
3.
Vet Pathol ; 45(3): 347-51, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18487491

RESUMO

This report describes an uncommon case of nonamyloidotic fibrillary glomerulonephritis. A 5-year-old female European cat was presented with nephrotic syndrome. Serum biochemistry and urinalysis revealed a mild increase in cholesterol, low total protein, severe hypoalbuminemia, and high proteinuria with a high protein-to-creatinine ratio. An histologic examination revealed an interstitial nephritis and a diffuse glomerulonephritis, with multifocal thickening of the Bowman's capsule. Transmission electron microscopy showed widespread fibrillary deposits in the glomerular basement membrane and in the mesangium. These fibrils ranged between 18 and 26 nm in diameter and were Congo red negative, which allowed their differentiation from amyloid. Immunohistochemistry demonstrated expression for immunoglobulin M (IgM) and immunoglobulin G (IgG) within the mesangium. Renal deposits of Congo red-negative amyloid-like fibrils have been described in humans, horses, monkeys, and dogs. This is the first report of noncongophilic fibrillary glomerulopathy in a cat.


Assuntos
Doenças do Gato/patologia , Glomerulonefrite/veterinária , Animais , Gatos , Feminino , Membrana Basal Glomerular/patologia , Imunoglobulina G/análise , Rim/imunologia , Rim/patologia , Ovariectomia/veterinária
4.
Vet Parasitol ; 151(2-4): 355-7, 2008 Feb 14.
Artigo em Inglês | MEDLINE | ID: mdl-18155360

RESUMO

A field trial was conducted to assess the safety and efficacy of oral administration of moxidectin in mice naturally infected with the fur mites Radfordia affinis. The natural infection was diagnosed in two colonies within a large academic institution by direct hair examination. Animals received moxidectin (1% Cydectin, FortDodge) at an oral dosage of approximately 2 mg/kg body weight by micropipette; administration was repeated after 15 days. Forty mice served as an untreated control group. Moxidectin treatment resulted in clinical improvement within a few days after initial treatment, and mites were eradicated from all infested animals at day 30. No side effects or signs of ill health were observed in any of the treated animals. To our knowledge, this is the first report of oral moxidectin for treatment of murine acariosis.


Assuntos
Inseticidas/uso terapêutico , Infestações por Ácaros/veterinária , Ácaros/efeitos dos fármacos , Doenças dos Roedores/tratamento farmacológico , Administração Oral , Animais , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Feminino , Inseticidas/normas , Macrolídeos/normas , Macrolídeos/uso terapêutico , Masculino , Camundongos , Camundongos Endogâmicos , Infestações por Ácaros/tratamento farmacológico , Infestações por Ácaros/parasitologia , Doenças dos Roedores/parasitologia , Fatores de Tempo
5.
Schweiz Arch Tierheilkd ; 149(6): 265-71, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17645036

RESUMO

Fluoroquinolones were originally developed for the Gram-negative aerobic spectrum, but the newer generation agents are also highly effective against some Gram-positive pathogens and cause few adverse effects. Owing to these characteristics, fluoroquinolones are often used in first line therapy in small animal practice. However, their widespread use has raised concern over emerging bacterial resistance. In this study we evaluated the in vitro efficacy of two fluoroquinolones, marbofloxacin and enrofloxacin, on field strains isolated from clinical infections between 2002 and 2005. Our data show that most of the isolates are still sensitive to both antimicrobials and marbofloxacin was more effective than enrofloxacin, especially against P. aeruginosa and beta-Streptococci (P < 0.01). beta-Streptococci demonstrated the greatest resistance to the two study drugs.


Assuntos
Antibacterianos/farmacologia , Doenças do Gato/tratamento farmacológico , Doenças do Cão/tratamento farmacológico , Fluoroquinolonas/farmacologia , Quinolonas/farmacologia , Animais , Gatos , Contagem de Colônia Microbiana/veterinária , Cães , Relação Dose-Resposta a Droga , Farmacorresistência Bacteriana , Enrofloxacina , Bactérias Gram-Negativas/efeitos dos fármacos , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Infecções por Bactérias Gram-Negativas/veterinária , Bactérias Gram-Positivas/efeitos dos fármacos , Infecções por Bactérias Gram-Positivas/tratamento farmacológico , Infecções por Bactérias Gram-Positivas/veterinária , Testes de Sensibilidade Microbiana/veterinária , Resultado do Tratamento
6.
Schweiz Arch Tierheilkd ; 148(12): 649-55, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17263082

RESUMO

In the present study we established a method for the determination of faecal glucocorticoid metabolites in dogs and then used the assay to evaluate the adrenocortical activity in 12 dogs divided into two groups. In group A faecal samples were collected at their domestic setting. In group B, faecal samples were collected at home prior to transport to a boarding kennel, where faecal samples were then collected. In faecal samples most of the steroids were extracted with methanol and determined using a radioimmunoassay with an anti-cortisol antibody. Dogs in group A did not show any statistically significant inter-day variations in the basal levels of faecal corticoid metabolites. Faecal corticoid metabolites in dogs in group B were significantly higher on the first day at the kennel compared to animals kept at home. The peak concentration was found after 24 hours and followed by a slow decline. These results suggest that extraction with methanol and dosage with an anti-cortisol antibody by radioimmunoassay represents a valid approach technique for determination of faecal glucocorticoid metabolites and accurately reflects adrenocortical activity.


Assuntos
Córtex Suprarrenal/fisiologia , Hormônio Adrenocorticotrópico/análise , Fezes/química , Radioimunoensaio/veterinária , Hormônio Adrenocorticotrópico/metabolismo , Animais , Doenças do Cão/diagnóstico , Cães , Feminino , Glucocorticoides/análise , Masculino , Radioimunoensaio/métodos , Sensibilidade e Especificidade , Estresse Fisiológico/metabolismo , Estresse Fisiológico/veterinária
7.
Pharmacol Res ; 36(1): 35-9, 1997 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9368912

RESUMO

The combined effects of the uterine infusion of EDTA-Tris solution and antibiotics have been evaluated in 75 cases of slight, moderate or severe bovine endometritis which did not respond to local routine antimicrobial therapy. Antibiotic-resistant bacteria were isolated from uterine swabs. The cows were divided into three groups on the basis of the severity of endometritis and treated with 100 ml of sterile EDTA-Tris solution (250 mM EDTA and 50 mM tris, pH 8) and the same antibiotic used in the first unsuccessful treatment (oxytetracycline, enrofloxacin, lincomycin-spectinomycin or amikacin). Control groups consisting of six animals treated with antibiotic alone were used. Clinical evaluations performed 2, 15, 21, 42 and 63 days after treatment revealed good therapeutic results, as 53 cows showed a complete recovery with renormalization of the subsequent oestrus cycle. Artificial insemination was followed by pregnancy in about 90% of treated cows. In control animals the second treatment performed using only the antibiotic gave variable and unsatisfactory results, particularly in animals affected by severe endometritis.


Assuntos
Amicacina/administração & dosagem , Antibacterianos/administração & dosagem , Anti-Infecciosos , Doenças dos Bovinos/tratamento farmacológico , Ácido Edético/administração & dosagem , Endometrite/veterinária , Fluoroquinolonas , Lincomicina/administração & dosagem , Oxitetraciclina/administração & dosagem , Quinolonas/administração & dosagem , Espectinomicina/administração & dosagem , Trometamina/administração & dosagem , Animais , Bovinos , Doença Crônica , Resistência Microbiana a Medicamentos , Enrofloxacina , Feminino , Instilação de Medicamentos , Soluções , Útero/microbiologia
8.
J Small Anim Pract ; 38(6): 243-5, 1997 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9200113

RESUMO

Possible synergistic effects of the combination of EDTA-tromethamine (EDTA-Tris) and three antimicrobial agents (cephaloridine, kanendomycin and enrofloxacin) against resistant Gram-positive and Gram-negative bacteria are reported. Bacteria were isolated from eight cases of chronic otitis externa, five cases of chronic dermatitis and four cases of recurrent cystitis in dogs which had previously been treated with one of the three antibiotics without success. Animals exposed to EDTA-tromethamine plus the antibiotic recovered completely within 10 days, and were controlled clinically and bacteriologically for 180 days. Local irrigation with EDTA-tromethamine solution was well tolerated and no side effects were recorded.


Assuntos
Antibacterianos/uso terapêutico , Cistite/veterinária , Dermatite/veterinária , Doenças do Cão/tratamento farmacológico , Ácido Edético/farmacologia , Fluoroquinolonas , Otite/veterinária , Trometamina/farmacologia , Animais , Anti-Infecciosos/uso terapêutico , Soluções Tampão , Cefaloridina/uso terapêutico , Cefalosporinas/uso terapêutico , Cistite/tratamento farmacológico , Cistite/microbiologia , Dermatite/tratamento farmacológico , Dermatite/microbiologia , Doenças do Cão/microbiologia , Cães , Sinergismo Farmacológico , Enrofloxacina , Infecções por Escherichia coli/complicações , Infecções por Escherichia coli/tratamento farmacológico , Infecções por Escherichia coli/veterinária , Feminino , Canamicina/análogos & derivados , Canamicina/uso terapêutico , Masculino , Otite/tratamento farmacológico , Otite/microbiologia , Infecções por Proteus/complicações , Infecções por Proteus/tratamento farmacológico , Infecções por Proteus/veterinária , Proteus mirabilis , Infecções por Pseudomonas/complicações , Infecções por Pseudomonas/tratamento farmacológico , Infecções por Pseudomonas/veterinária , Quinolonas/uso terapêutico , Infecções Estafilocócicas/complicações , Infecções Estafilocócicas/tratamento farmacológico , Infecções Estafilocócicas/veterinária , Fatores de Tempo
9.
Vet Res Commun ; 18(1): 1-6, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-8091636

RESUMO

The in vitro synergistic effects of combinations of EDTA-tromethamine and five antimicrobial agents (ampicillin, cephalexin, oxytetracycline, streptomycin and sulphadimethoxine) on three clinically isolated Gram-positive bacteria (Staphylococcus aureus, Staphylococcus hominis and Streptococcus faecium) were investigated. The bacteria had been isolated from three cases of canine otitis resistant to beta-lactam antibiotic therapy. The antimicrobial activity was evaluated by measuring the minimal inhibitory concentration for the antibiotics alone or in combination with EDTA-tromethamine. EDTA-tromethamine potentiated the activity of cefalexin against S. aureus and S. hominis, of oxytetracycline against S. aureus and S. faecium and of streptomycin against S. faecium. No significant effects were noted on the activity of oxytetracycline against S. hominis. The remaining combinations gave a slight synergistic effect. As previously shown for Gram-negative resistant bacteria, these data suggest that the association of EDTA-tromethamine and appropriate antibiotic therapy may be useful to overcome persistent infections of soft tissues in domestic animals.


Assuntos
Antibacterianos/farmacologia , Ácido Edético/farmacologia , Bactérias Gram-Positivas/efeitos dos fármacos , Trometamina/farmacologia , Animais , Doenças do Cão/microbiologia , Cães , Resistência Microbiana a Medicamentos , Sinergismo Farmacológico , Enterococcus faecium/efeitos dos fármacos , Testes de Sensibilidade Microbiana , Otite/microbiologia , Otite/veterinária , Staphylococcus/efeitos dos fármacos
10.
Vet Res Commun ; 17(2): 77-84, 1993.
Artigo em Inglês | MEDLINE | ID: mdl-8212526

RESUMO

The in vitro synergistic effects of combinations of EDTA-tromethamine and six antimicrobial agents (ampicillin, chloramphenicol, oxytetracycline, streptomycin, nalidixic acid and sulphadimethoxine) on clinically isolated strains of Pseudomonas aeruginosa, Proteus mirabilis and Escherichia coli were investigated. The antibacterial activity was assessed from the minimal inhibitory concentration for the antibiotics alone or in combination with EDTA-tromethamine. EDTA-tromethamine potentiated the antibacterial activity of ampicillin, chloramphenicol, oxytetracycline and streptomycin up to four-fold. There were no significant or consistent synergistic effects with nalidixic acid or sulphadimethoxine.


Assuntos
Antibacterianos/farmacologia , Ácido Edético/farmacologia , Bactérias Gram-Negativas/efeitos dos fármacos , Trometamina/farmacologia , Relação Dose-Resposta a Droga , Sinergismo Farmacológico , Escherichia coli/efeitos dos fármacos , Escherichia coli/crescimento & desenvolvimento , Bactérias Gram-Negativas/crescimento & desenvolvimento , Testes de Sensibilidade Microbiana , Proteus mirabilis/efeitos dos fármacos , Proteus mirabilis/crescimento & desenvolvimento , Pseudomonas aeruginosa/efeitos dos fármacos , Pseudomonas aeruginosa/crescimento & desenvolvimento
11.
Pharmacol Res ; 22(2): 79-86, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2330344

RESUMO

Intrauterine administration was performed in six Friesan cows with a disposable spray preparation containing 3 g of sulfamonomethoxine and 3 g of oxytetracycline, in order to investigate their serum kinetics. Sulfamonomethoxine levels were determined by a reversed-phase HPLC method, whilst oxytetracycline quantities were detected by a microbiological method. The sulphonamide had a peak 1.17 h after the administration, the tetracycline reached its highest concentration after 8 h. The bioavailability of both drugs was low and detectable drug amounts were no longer recovered after 24 h.


Assuntos
Oxitetraciclina/farmacocinética , Sulfamonometoxina/farmacocinética , Sulfanilamidas/farmacocinética , Animais , Disponibilidade Biológica , Bovinos , Cromatografia Líquida de Alta Pressão , Feminino , Injeções , Oxitetraciclina/administração & dosagem , Oxitetraciclina/sangue , Espectrofotometria Ultravioleta , Sulfamonometoxina/administração & dosagem , Sulfamonometoxina/sangue , Útero
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...